Skip to main content

Table 1 Patient demographic data

From: Patient and clinician-reported experiences of using electronic patient reported outcome measures (ePROMs) as part of routine cancer care

Patient demographics

Characteristic

All N = 100 n(%)

Lung N = 78 n(%)

Head and neck N = 22 n(%)

Age (years)

 Median (range)

67 (30–80)

68.5 (40–80)

63.5 (30–74)

Gender

 Male

50 (50.0)

36 (46.2)

14 (63.6)

 Female

50 (50.0)

42 (53.8)

8 (36.4)

Stage

 I

3 (3.0)

2 (2.6)

1 (4.5)

 II

6 (6.0)

2 (2.5)

4 (18.2)

 III

38 (38.0)

32 (41.1)

6 (27.3)

 IV

41 (41.0)

36 (46.2)

5 (22.7)

 Limited*

2 (2.0)

2 (2.6)

-

 Extensive*

2 (2.0)

2 (2.5)

-

 Unknown

8 (8.0)

2 (2.5)

6 (27.3)

PS

   

 0

41 (41.0)

26 (33.3)

15 (68.2)

 1

45 (45.0)

40 (51.3)

5 (22.7)

 2

14 (14.0)

12 (15.4)

2 (9.1)

ACE comorbidity Score

 0 (None)

37 (37.0)

26 (33.3)

11 (50.0)

 1 (Mild)

39 (39.0)

31 (39.7)

8 (36.4)

 2 (Moderate)

17 (17.0)

16 (20.5)

1 (4.5)

 3 (Severe)

7 (7.0)

5 (6.5)

2 (9.1)

  1. Numbers in italics indicate percentage of total responses
  2. Where ACE comorbidity scores were unavailable they were calculated by the researcher from the medical notes
  3. ACE- Adult Comorbidity Evaluation, PS- Performance Status.* limited/extensive stage used for patients with small cell lung cancer